The future of complement therapeutics

Complement is both evolutionary and scientifically old. It predates the adaptive immunity by some 600 million years and was first described in 1905 by Jules Bordet and Paul Ehrlich. For the most of its, the existence complement system has been ignored by most scientists and clinicians due to the per...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Exploration of immunology Ročník 4; číslo 5; s. 577 - 615
Hlavní autori: Kolev, Martin, Rao, Kollu Nageswara, Yeh, Michael, Parikh, Atman, Deschatelets, Pascal
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Open Exploration Publishing Inc 18.10.2024
Predmet:
complement
complement therapeutics
complement-mediated disease
gene therapy
ISSN:2768-6655, 2768-6655
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Complement is both evolutionary and scientifically old. It predates the adaptive immunity by some 600 million years and was first described in 1905 by Jules Bordet and Paul Ehrlich. For the most of its, the existence complement system has been ignored by most scientists and clinicians due to the perception of it being complicated and its relevance for the pathogenesis of human disease being unclear. With the recent US Food and Drug Administration (FDA) approvals of pegcetacoplan for both paroxysmal nocturnal haemoglobinuria (PNH) and geographic atrophy (GA), avacincaptad pegol for GA and iptacopan and danicopan for PNH, we are at a crucial juncture for complement-targeting therapies. A number of companies and academic institutions are developing next-generation complement therapies, which is resulting in an increasingly competitive landscape. If one looks at the serum complement cascade, all 3 pathways now have biotechnology or pharmaceutical industry players with 1 or multiple clinical-stage inhibitors that are expected to be FDA approved within the next few years. Furthermore, with the limited number of clinically validated targets in complement-mediated disease, the competition in this space is set to further intensify in the coming years. In this review, we will discuss the timeline of the academic discoveries that led to the development of the current crop of FDA-approved complement therapeutics. We follow with a discussion of an increasingly crowded complement therapy space and of the scientific advances that have emerged in recent two decades underpinning future innovation, including advances in our understanding of complement biology, such as local and intracellular complement, emerging complement targets, combinational approaches of complement and non-complement therapeutics to unlock new disease indications and new technologies such as gene therapy. We will also give a comprehensive overview of the gene therapy landscape and how it can be utilized to target complement dysregulation.
AbstractList Complement is both evolutionary and scientifically old. It predates the adaptive immunity by some 600 million years and was first described in 1905 by Jules Bordet and Paul Ehrlich. For the most of its, the existence complement system has been ignored by most scientists and clinicians due to the perception of it being complicated and its relevance for the pathogenesis of human disease being unclear. With the recent US Food and Drug Administration (FDA) approvals of pegcetacoplan for both paroxysmal nocturnal haemoglobinuria (PNH) and geographic atrophy (GA), avacincaptad pegol for GA and iptacopan and danicopan for PNH, we are at a crucial juncture for complement-targeting therapies. A number of companies and academic institutions are developing next-generation complement therapies, which is resulting in an increasingly competitive landscape. If one looks at the serum complement cascade, all 3 pathways now have biotechnology or pharmaceutical industry players with 1 or multiple clinical-stage inhibitors that are expected to be FDA approved within the next few years. Furthermore, with the limited number of clinically validated targets in complement-mediated disease, the competition in this space is set to further intensify in the coming years. In this review, we will discuss the timeline of the academic discoveries that led to the development of the current crop of FDA-approved complement therapeutics. We follow with a discussion of an increasingly crowded complement therapy space and of the scientific advances that have emerged in recent two decades underpinning future innovation, including advances in our understanding of complement biology, such as local and intracellular complement, emerging complement targets, combinational approaches of complement and non-complement therapeutics to unlock new disease indications and new technologies such as gene therapy. We will also give a comprehensive overview of the gene therapy landscape and how it can be utilized to target complement dysregulation.
Author Deschatelets, Pascal
Parikh, Atman
Yeh, Michael
Kolev, Martin
Rao, Kollu Nageswara
Author_xml – sequence: 1
  givenname: Martin
  orcidid: 0000-0002-7208-3875
  surname: Kolev
  fullname: Kolev, Martin
  organization: Discovery, Apellis Pharmaceuticals, Waltham, MA 02451, USA
– sequence: 2
  givenname: Kollu Nageswara
  surname: Rao
  fullname: Rao, Kollu Nageswara
  organization: Discovery, Apellis Pharmaceuticals, Waltham, MA 02451, USA
– sequence: 3
  givenname: Michael
  surname: Yeh
  fullname: Yeh, Michael
  organization: Medical Affairs, Apellis Pharmaceuticals, Waltham, MA 02451, USA
– sequence: 4
  givenname: Atman
  surname: Parikh
  fullname: Parikh, Atman
  organization: Global Business Intelligence and Commercial Opperations, Apellis Pharmaceuticals, Waltham, MA 02451, USA
– sequence: 5
  givenname: Pascal
  surname: Deschatelets
  fullname: Deschatelets, Pascal
  organization: Discovery, Apellis Pharmaceuticals, Waltham, MA 02451, USA
BookMark eNp1kEtLAzEUhYNUsNZuXc_G5Yw3mUweSyk-CgU3dR0yyY1NmU5KZrrw31tbBRFc3cOF7-NwrsmkTz0SckuhqmXN9T3GigHjFQAV9IJMmRSqFKJpJr_yFZkPwxYAmJJcc5iSu_UGi3AYDxmLFAqXdvsOd9iPxbjBbPd4GKMbbshlsN2A8-87I29Pj-vFS7l6fV4uHlalYwJo6VpQNXqpJErbeMqFYMKD4LVVLSCldYteaR8EgpOCUgleSWe1QI00tPWMLM9en-zW7HPc2fxhko3m9Ej53dh8LNSh8VqAZ6gDV4zrllvf1tQr1XIFDdfh6OJnl8tpGDIG4-Jox5j6MdvYGQrmtJzBaL6WM6fljlj1B_up8Q_wCQLEcD0
CitedBy_id crossref_primary_10_3390_pharmaceutics17040450
crossref_primary_10_1080_17568919_2025_2498876
crossref_primary_10_1016_j_ekir_2025_07_015
Cites_doi 10.1016/j.cellsig.2023.110944
10.1126/science.aat5011
10.1016/j.imbio.2012.06.003
10.1186/s13578-024-01216-6
10.1177/0961203320950019
10.1126/science.add8643
10.1016/j.molimm.2009.09.005
10.3390/ijms242216515
10.1007/s40259-017-0234-5
10.1177/2042018821997320
10.2147/cia.s325026
10.1074/jbc.m307764200
10.1172/jci112773
10.1038/s41584-023-00925-5
10.1681/asn.0000000000000192
10.1038/s41467-018-06706-z
10.3389/fimmu.2017.00001
10.1016/j.msard.2021.102787
10.1002/art.24622
10.1182/blood.v92.11.4439.423k24_4439_4445
10.1126/sciimmunol.abf2489
10.1056/nejmoa2107454
10.1007/s00281-017-0646-9
10.1111/imr.13138
10.1016/j.jaut.2022.102979
10.1182/blood.v84.8.2604.2604
10.2217/imt-2020-0163
10.1007/s40291-024-00705-1
10.1093/brain/awz188
10.1186/s12974-023-02850-6
10.1097/md.0000000000037297
10.1056/evidoa2100066
10.1016/j.molimm.2019.07.030
10.1080/15548627.2019.1580515
10.4049/jimmunol.126.1.232
10.1002/ajh.25960
10.1038/nri3761
10.1186/s40942-023-00493-6
10.1111/imr.12852
10.1016/j.molimm.2017.06.121
10.1093/ndt/gfw453
10.1126/sciadv.abo2341
10.1016/j.immuni.2015.05.024
10.1016/j.smim.2019.101339
10.1016/j.ajpath.2020.02.006
10.4103/ijo.ijo_82_22
10.1016/j.ijbiomac.2023.125185
10.1038/ni.1917
10.1016/j.imbio.2023.152393
10.1186/s12967-016-1013-7
10.1016/j.gde.2024.102195
10.1007/s40265-021-01480-7
10.1002/ana.21524
10.1016/j.copbio.2024.103071
10.3390/ijms24054778
10.3389/fimmu.2015.00257
10.1200/jco.21.02389
10.1111/ejh.13640
10.3389/fgene.2023.1209416
10.1038/s41587-020-0561-9
10.1126/science.aad8373
10.1016/bs.ai.2021.09.001
10.1016/j.immuni.2008.02.001
10.1212/nxi.0000000000001107
10.1111/bph.15168
10.3389/fimmu.2018.01388
10.1126/science.1231143
10.1001/jama.2023.6293
10.1002/art.34430
10.1134/s0006297922080090
10.4049/jimmunol.177.3.1904
10.1111/ejh.14026
10.1111/bph.15238
10.1038/nbt.4172
10.3390/jcm12062335
10.4049/jimmunol.1901068
10.1056/nejmoa031688
10.1007/s12033-022-00639-1
10.1016/j.molimm.2017.05.012
10.1007/bf02722692
10.1007/s40265-022-01711-5
10.1016/j.molimm.2006.07.004
10.3389/fimmu.2021.607641
10.1590/1984-3143-ar2023-0089
10.1038/emboj.2009.184
10.1016/j.addr.2023.114990
10.1084/jem.172.1.367
10.3389/fgene.2024.1364742
10.1002/wrna.1844
10.1177/039463201002300202
10.1073/pnas.81.3.881
10.1056/nejmoa2027760
10.1002/hep.23228
10.1111/j.1365-2249.2004.02627.x
10.1002/eji.1830151210
10.1016/j.molimm.2015.02.027
10.1016/j.cell.2013.08.021
10.1080/10409238.2024.2320659
10.1038/s41587-022-01643-1
10.1016/0167-5699(84)90044-6
10.1093/emboj/19.2.164
10.1084/jem.123.6.969
10.1007/s40265-021-01560-8
10.1126/science.1225829
10.1016/s2213-2600(23)00423-x
10.1097/tp.0b013e31827e31c9
10.1093/rheumatology/kem222
10.1097/00007890-199512000-00025
10.1016/j.semarthrit.2018.11.005
10.1016/j.semnephrol.2013.08.003
10.1016/s0925-4439(00)00042-9
10.1371/journal.pone.0110053
10.1046/j.1365-2958.2002.02839.x
10.1590/s1679-45082017rb4024
10.1016/j.transproceed.2017.02.044
10.1002/dmrr.3716
10.1038/s41573-020-0084-6
10.1111/imr.13131
10.1016/S0140-6736(23)01520-9
10.1038/nri2231
10.1002/jha2.748
10.1634/theoncologist.2008-0086
10.1007/s40262-019-00742-8
10.1016/j.molimm.2009.04.029
10.1016/j.biotechadv.2010.07.005
10.3389/fimmu.2015.00262
10.1182/blood-2023-180866
10.1038/s41586-021-03534-y
10.1056/nejmoa1609243
10.1186/s40942-022-00431-y
10.1056/nejmoa2309000
10.1016/j.immuni.2013.10.018
10.1111/imr.13149
10.1038/s41589-023-01531-y
10.1016/j.cell.2024.01.042
10.1128/mcb.21.1.289-297.2001
10.1038/s41586-019-1711-4
10.1056/nejmoa061648
10.1111/j.1365-2249.2008.03830.x
10.1007/s40265-023-01940-2
10.1056/nejmoa022836
10.1038/s41467-021-26714-w
10.1038/nature17946
10.1126/science.1195821
10.1038/ni.1625
10.1007/s40265-019-01068-2
10.1172/jci105389
10.1111/ajt.15777
10.2147/tcrm.s266031
10.3389/fimmu.2022.1054159
10.1016/j.trsl.2022.03.005
10.4049/jimmunol.170.3.1517
10.1056/NEJM200104053441406
10.1016/j.cell.2007.10.036
10.1159/000463072
10.1681/asn.2011111072
10.1056/nejmoa1208981
10.1016/j.semarthrit.2023.152256
10.4049/jimmunol.0902310
10.1016/j.tips.2022.01.004
10.1016/j.medj.2024.01.011
10.1073/pnas.90.11.5272
10.1016/j.crimmu.2022.05.003
10.1182/blood-2011-06-359646
10.1016/j.ajps.2023.100854
10.4049/jimmunol.1400752
10.1016/j.biopha.2022.113324
10.1038/ng912
10.1016/j.lfs.2022.120375
10.3389/fimmu.2021.629986
10.1093/ckj/sfv076
10.1111/eci.12275
10.1101/2022.05.17.492303
10.3389/fimmu.2017.01093
10.1002/jgm.3015
10.1016/j.omtm.2019.01.008
10.2147/oarrr.s318826
10.1007/s40120-020-00208-1
10.3390/jcm10040626
10.1038/d41587-023-00016-6
10.1681/ASN.V11101957
10.1016/j.ymthe.2024.01.005
10.1073/pnas.1019338108
10.1107/s0907444909000389
10.1016/j.ophtha.2024.06.013
10.1016/j.ijbiomac.2024.131802
10.3390/cells11121881
10.1016/j.cell.2021.03.025
10.1172/jci118195
10.1038/s41392-023-01309-7
10.1073/pnas.82.3.859
10.1038/s41467-020-19505-2
10.1056/nejmoa2029073
10.1080/14712598.2023.2183771
10.4049/jimmunol.156.8.3051
10.1016/s0161-5890(96)00078-8
10.1016/j.ekir.2020.10.009
10.3389/fimmu.2018.01057
10.3389/fimmu.2022.931273
10.1016/j.imbio.2023.152410
10.1111/bjh.15790
10.1016/s2352-3026(23)00315-0
10.1007/s10238-019-00565-8
10.1159/000463204
10.1016/j.omtn.2024.102138
10.1101/2022.01.28.478207
10.4049/jimmunol.0903678
10.1126/science.adg7942
10.1038/ni.1655
10.1016/s0140-6736(23)01524-6
10.1126/science.1110359
10.2217/epi-2023-0281
10.3390/ijms222413647
10.1016/j.cell.2020.03.023
10.1155/2018/6051083
10.1016/j.exer.2022.109248
10.1002/ana.1255
10.1016/j.immuni.2020.02.006
10.1016/j.imbio.2012.08.232
10.1126/science.aad1210
10.1007/s00281-017-0663-8
10.1038/s41467-023-42189-3
10.1038/ng.439
10.1016/j.smim.2018.02.003
10.1002/ana.26626
10.1681/asn.2004050380
10.1016/j.omtm.2017.08.001
10.4049/jimmunol.134.1.512
10.1016/j.ajo.2024.02.021
10.1126/sciadv.aao4774
10.1007/BF01540901
10.1152/ajpcell.00191.2022
10.1038/s41593-020-0672-0
10.1016/0161-5890(95)00099-2
10.1016/j.jneuroim.2021.577767
10.1182/blood-2022-163625
10.1371/journal.pone.0195909
10.4049/jimmunol.157.2.884
10.1124/pharmrev.120.000072
10.3390/biology12020186
10.1038/nature04005
10.1007/s00467-014-2863-y
10.1038/s41573-023-00762-x
10.1038/s12276-023-01086-x
10.1182/bloodadvances.2018020644
10.1016/j.imbio.2016.06.007
10.1016/j.cell.2021.12.040
10.1172/jci112522
10.1002/prot.340030302
10.1093/ndt/gfad140
10.1056/nejmoa2212948
10.1038/nbt1344
10.1007/s00018-021-03796-9
10.1038/s41581-018-0071-x
10.1007/s40265-021-01643-6
10.1038/nrg2971
10.1182/blood-2008-04-151068
10.1016/j.immuni.2016.08.003
10.1007/s40265-023-01948-8
10.1016/j.blre.2022.100995
10.1074/jbc.m305175200
10.1172/jci24521
10.4049/jimmunol.1300780
10.1038/ncomms10587
10.1016/j.heliyon.2023.e19072
ContentType Journal Article
DBID AAYXX
CITATION
DOA
DOI 10.37349/ei.2024.00161
DatabaseName CrossRef
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
DatabaseTitleList
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2768-6655
EndPage 615
ExternalDocumentID oai_doaj_org_article_d960d2e9f48249b4adb31d88b480549f
10_37349_ei_2024_00161
GroupedDBID AAYXX
ALMA_UNASSIGNED_HOLDINGS
CITATION
GROUPED_DOAJ
M~E
OK1
ID FETCH-LOGICAL-c2601-cb083ed787e7a5d146626d0643a8b0e113bed89df6e0c761170d87ca96e9e1fb3
IEDL.DBID DOA
ISSN 2768-6655
IngestDate Fri Oct 03 12:50:39 EDT 2025
Sat Nov 29 04:43:32 EST 2025
Tue Nov 18 22:37:31 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 5
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2601-cb083ed787e7a5d146626d0643a8b0e113bed89df6e0c761170d87ca96e9e1fb3
ORCID 0000-0002-7208-3875
OpenAccessLink https://doaj.org/article/d960d2e9f48249b4adb31d88b480549f
PageCount 39
ParticipantIDs doaj_primary_oai_doaj_org_article_d960d2e9f48249b4adb31d88b480549f
crossref_citationtrail_10_37349_ei_2024_00161
crossref_primary_10_37349_ei_2024_00161
PublicationCentury 2000
PublicationDate 2024-10-18
PublicationDateYYYYMMDD 2024-10-18
PublicationDate_xml – month: 10
  year: 2024
  text: 2024-10-18
  day: 18
PublicationDecade 2020
PublicationTitle Exploration of immunology
PublicationYear 2024
Publisher Open Exploration Publishing Inc
Publisher_xml – name: Open Exploration Publishing Inc
References ref57
ref207
ref56
ref208
ref59
ref205
ref58
ref206
ref53
ref203
ref52
ref204
ref55
ref201
ref54
ref202
ref209
ref210
ref211
ref51
ref50
ref46
ref218
ref45
ref219
ref48
ref216
ref47
ref217
ref42
ref214
ref41
ref215
ref44
ref212
ref43
ref213
ref49
ref8
ref7
ref9
ref4
ref3
ref6
ref5
ref100
ref221
ref101
ref222
ref40
ref220
ref35
ref34
ref37
ref36
ref31
ref30
ref33
ref32
ref39
ref38
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref200
ref128
ref249
ref129
ref97
ref126
ref247
ref96
ref127
ref248
ref99
ref124
ref245
ref98
ref125
ref246
ref93
ref133
ref254
ref92
ref134
ref255
ref95
ref131
ref252
ref94
ref132
ref253
ref250
ref130
ref251
ref91
ref90
ref89
ref139
ref86
ref137
ref258
ref85
ref138
ref259
ref88
ref135
ref256
ref87
ref136
ref257
ref82
ref144
ref265
ref81
ref145
ref266
ref84
ref142
ref263
ref83
ref143
ref264
ref140
ref261
ref141
ref262
ref80
ref260
ref79
ref108
ref229
ref78
ref109
ref106
ref227
ref107
ref228
ref75
ref104
ref225
ref74
ref105
ref226
ref77
ref102
ref223
ref76
ref103
ref224
ref71
ref111
ref232
ref70
ref112
ref233
ref73
ref230
ref72
ref110
ref231
ref68
ref119
ref67
ref117
ref238
ref69
ref118
ref239
ref64
ref115
ref236
ref63
ref116
ref237
ref66
ref113
ref234
ref65
ref114
ref235
ref60
ref122
ref243
ref123
ref244
ref62
ref120
ref241
ref61
ref121
ref242
ref240
ref168
ref169
ref170
ref177
ref178
ref175
ref176
ref173
ref174
ref171
ref172
ref179
ref180
ref181
ref188
ref189
ref186
ref187
ref184
ref185
ref182
ref183
ref148
ref269
ref149
ref146
ref267
ref147
ref268
ref155
ref156
ref153
ref154
ref151
ref152
ref270
ref150
ref271
ref159
ref157
ref158
ref166
ref167
ref164
ref165
ref162
ref163
ref160
ref161
ref13
ref12
ref15
ref14
ref11
ref10
ref17
ref16
ref19
ref18
ref0
ref2
ref1
ref191
ref192
ref190
ref199
ref197
ref198
ref195
ref196
ref193
ref194
References_xml – ident: ref155
  doi: 10.1016/j.cellsig.2023.110944
– ident: ref216
  doi: 10.1126/science.aat5011
– ident: ref92
  doi: 10.1016/j.imbio.2012.06.003
– ident: ref236
  doi: 10.1186/s13578-024-01216-6
– ident: ref166
  doi: 10.1177/0961203320950019
– ident: ref218
  doi: 10.1126/science.add8643
– ident: ref11
  doi: 10.1016/j.molimm.2009.09.005
– ident: ref123
  doi: 10.3390/ijms242216515
– ident: ref207
  doi: 10.1007/s40259-017-0234-5
– ident: ref157
  doi: 10.1177/2042018821997320
– ident: ref135
  doi: 10.2147/cia.s325026
– ident: ref41
  doi: 10.1074/jbc.m307764200
– ident: ref62
  doi: 10.1172/jci112773
– ident: ref168
  doi: 10.1038/s41584-023-00925-5
– ident: ref268
– ident: ref130
  doi: 10.1681/asn.0000000000000192
– ident: ref188
  doi: 10.1038/s41467-018-06706-z
– ident: ref15
  doi: 10.3389/fimmu.2017.00001
– ident: ref140
  doi: 10.1016/j.msard.2021.102787
– ident: ref170
  doi: 10.1002/art.24622
– ident: ref65
  doi: 10.1182/blood.v92.11.4439.423k24_4439_4445
– ident: ref194
  doi: 10.1126/sciimmunol.abf2489
– ident: ref221
  doi: 10.1056/nejmoa2107454
– ident: ref7
  doi: 10.1007/s00281-017-0646-9
– ident: ref2
  doi: 10.1111/imr.13138
– ident: ref30
  doi: 10.1016/j.jaut.2022.102979
– ident: ref66
  doi: 10.1182/blood.v84.8.2604.2604
– ident: ref79
  doi: 10.2217/imt-2020-0163
– ident: ref245
  doi: 10.1007/s40291-024-00705-1
– ident: ref138
  doi: 10.1093/brain/awz188
– ident: ref53
  doi: 10.1186/s12974-023-02850-6
– ident: ref141
  doi: 10.1097/md.0000000000037297
– ident: ref84
  doi: 10.1056/evidoa2100066
– ident: ref86
  doi: 10.1016/j.molimm.2019.07.030
– ident: ref74
– ident: ref195
  doi: 10.1080/15548627.2019.1580515
– ident: ref20
  doi: 10.4049/jimmunol.126.1.232
– ident: ref94
  doi: 10.1002/ajh.25960
– ident: ref4
  doi: 10.1038/nri3761
– ident: ref58
  doi: 10.1186/s40942-023-00493-6
– ident: ref16
  doi: 10.1111/imr.12852
– ident: ref36
  doi: 10.1016/j.molimm.2017.06.121
– ident: ref148
  doi: 10.1093/ndt/gfw453
– ident: ref99
  doi: 10.1126/sciadv.abo2341
– ident: ref185
  doi: 10.1016/j.immuni.2015.05.024
– ident: ref169
  doi: 10.1016/j.smim.2019.101339
– ident: ref14
  doi: 10.1016/j.ajpath.2020.02.006
– ident: ref206
  doi: 10.4103/ijo.ijo_82_22
– ident: ref250
  doi: 10.1016/j.ijbiomac.2023.125185
– ident: ref186
  doi: 10.1038/ni.1917
– ident: ref161
  doi: 10.1016/j.imbio.2023.152393
– ident: ref128
  doi: 10.1186/s12967-016-1013-7
– ident: ref235
  doi: 10.1016/j.gde.2024.102195
– ident: ref251
  doi: 10.1007/s40265-021-01480-7
– ident: ref137
  doi: 10.1002/ana.21524
– ident: ref231
  doi: 10.1016/j.copbio.2024.103071
– ident: ref234
  doi: 10.3390/ijms24054778
– ident: ref13
  doi: 10.3389/fimmu.2015.00257
– ident: ref108
  doi: 10.1200/jco.21.02389
– ident: ref109
  doi: 10.1111/ejh.13640
– ident: ref202
  doi: 10.3389/fgene.2023.1209416
– ident: ref229
  doi: 10.1038/s41587-020-0561-9
– ident: ref267
– ident: ref52
  doi: 10.1126/science.aad8373
– ident: ref12
  doi: 10.1016/bs.ai.2021.09.001
– ident: ref26
  doi: 10.1016/j.immuni.2008.02.001
– ident: ref107
  doi: 10.1212/nxi.0000000000001107
– ident: ref191
  doi: 10.1111/bph.15168
– ident: ref143
  doi: 10.3389/fimmu.2018.01388
– ident: ref215
  doi: 10.1126/science.1231143
– ident: ref89
  doi: 10.1001/jama.2023.6293
– ident: ref183
  doi: 10.1002/art.34430
– ident: ref271
  doi: 10.1134/s0006297922080090
– ident: ref171
  doi: 10.4049/jimmunol.177.3.1904
– ident: ref104
  doi: 10.1111/ejh.14026
– ident: ref192
  doi: 10.1111/bph.15238
– ident: ref226
  doi: 10.1038/nbt.4172
– ident: ref129
  doi: 10.3390/jcm12062335
– ident: ref132
  doi: 10.4049/jimmunol.1901068
– ident: ref67
  doi: 10.1056/nejmoa031688
– ident: ref262
  doi: 10.1007/s12033-022-00639-1
– ident: ref184
  doi: 10.1016/j.molimm.2017.05.012
– ident: ref35
  doi: 10.1007/bf02722692
– ident: ref103
  doi: 10.1007/s40265-022-01711-5
– ident: ref112
  doi: 10.1016/j.molimm.2006.07.004
– ident: ref105
  doi: 10.3389/fimmu.2021.607641
– ident: ref217
  doi: 10.1590/1984-3143-ar2023-0089
– ident: ref45
  doi: 10.1038/emboj.2009.184
– ident: ref253
  doi: 10.1016/j.addr.2023.114990
– ident: ref22
  doi: 10.1084/jem.172.1.367
– ident: ref213
  doi: 10.3389/fgene.2024.1364742
– ident: ref238
  doi: 10.1002/wrna.1844
– ident: ref34
  doi: 10.1177/039463201002300202
– ident: ref19
  doi: 10.1073/pnas.81.3.881
– ident: ref102
  doi: 10.1056/nejmoa2027760
– ident: ref149
  doi: 10.1002/hep.23228
– ident: ref10
  doi: 10.1111/j.1365-2249.2004.02627.x
– ident: ref18
  doi: 10.1002/eji.1830151210
– ident: ref154
  doi: 10.1016/j.molimm.2015.02.027
– ident: ref220
  doi: 10.1016/j.cell.2013.08.021
– ident: ref232
  doi: 10.1080/10409238.2024.2320659
– ident: ref248
  doi: 10.1038/s41587-022-01643-1
– ident: ref17
  doi: 10.1016/0167-5699(84)90044-6
– ident: ref39
  doi: 10.1093/emboj/19.2.164
– ident: ref59
  doi: 10.1084/jem.123.6.969
– ident: ref95
  doi: 10.1007/s40265-021-01560-8
– ident: ref214
  doi: 10.1126/science.1225829
– ident: ref163
  doi: 10.1016/s2213-2600(23)00423-x
– ident: ref122
  doi: 10.1097/tp.0b013e31827e31c9
– ident: ref175
  doi: 10.1093/rheumatology/kem222
– ident: ref266
  doi: 10.1097/00007890-199512000-00025
– ident: ref144
  doi: 10.1016/j.semarthrit.2018.11.005
– ident: ref111
  doi: 10.1016/j.semnephrol.2013.08.003
– ident: ref133
  doi: 10.1016/s0925-4439(00)00042-9
– ident: ref151
  doi: 10.1371/journal.pone.0110053
– ident: ref219
  doi: 10.1046/j.1365-2958.2002.02839.x
– ident: ref198
  doi: 10.1590/s1679-45082017rb4024
– ident: ref117
  doi: 10.1016/j.transproceed.2017.02.044
– ident: ref156
  doi: 10.1002/dmrr.3716
– ident: ref255
  doi: 10.1038/s41573-020-0084-6
– ident: ref263
  doi: 10.1111/imr.13131
– ident: ref180
– ident: ref96
  doi: 10.1016/S0140-6736(23)01520-9
– ident: ref43
  doi: 10.1038/nri2231
– ident: ref100
  doi: 10.1002/jha2.748
– ident: ref76
  doi: 10.1634/theoncologist.2008-0086
– ident: ref80
  doi: 10.1007/s40262-019-00742-8
– ident: ref31
  doi: 10.1016/j.molimm.2009.04.029
– ident: ref197
  doi: 10.1016/j.biotechadv.2010.07.005
– ident: ref5
  doi: 10.3389/fimmu.2015.00262
– ident: ref256
  doi: 10.1182/blood-2023-180866
– ident: ref259
  doi: 10.1038/s41586-021-03534-y
– ident: ref260
  doi: 10.1056/nejmoa1609243
– ident: ref56
  doi: 10.1186/s40942-022-00431-y
– ident: ref24
– ident: ref152
  doi: 10.1056/nejmoa2309000
– ident: ref8
  doi: 10.1016/j.immuni.2013.10.018
– ident: ref203
  doi: 10.1111/imr.13149
– ident: ref240
  doi: 10.1038/s41589-023-01531-y
– ident: ref227
  doi: 10.1016/j.cell.2024.01.042
– ident: ref212
  doi: 10.1128/mcb.21.1.289-297.2001
– ident: ref230
  doi: 10.1038/s41586-019-1711-4
– ident: ref38
  doi: 10.1056/nejmoa061648
– ident: ref139
  doi: 10.1111/j.1365-2249.2008.03830.x
– ident: ref120
  doi: 10.1007/s40265-023-01940-2
– ident: ref32
  doi: 10.1056/nejmoa022836
– ident: ref244
  doi: 10.1038/s41467-021-26714-w
– ident: ref224
  doi: 10.1038/nature17946
– ident: ref44
  doi: 10.1126/science.1195821
– ident: ref49
  doi: 10.1038/ni.1625
– ident: ref85
  doi: 10.1007/s40265-019-01068-2
– ident: ref60
  doi: 10.1172/jci105389
– ident: ref127
  doi: 10.1111/ajt.15777
– ident: ref258
  doi: 10.2147/tcrm.s266031
– ident: ref150
  doi: 10.3389/fimmu.2022.1054159
– ident: ref164
  doi: 10.1016/j.trsl.2022.03.005
– ident: ref124
  doi: 10.4049/jimmunol.170.3.1517
– ident: ref3
  doi: 10.1056/NEJM200104053441406
– ident: ref51
  doi: 10.1016/j.cell.2007.10.036
– ident: ref63
  doi: 10.1159/000463072
– ident: ref125
  doi: 10.1681/asn.2011111072
– ident: ref77
  doi: 10.1056/nejmoa1208981
– ident: ref147
  doi: 10.1016/j.semarthrit.2023.152256
– ident: ref46
  doi: 10.4049/jimmunol.0902310
– ident: ref91
  doi: 10.1016/j.tips.2022.01.004
– ident: ref159
  doi: 10.1016/j.medj.2024.01.011
– ident: ref64
  doi: 10.1073/pnas.90.11.5272
– ident: ref177
  doi: 10.1016/j.crimmu.2022.05.003
– ident: ref182
  doi: 10.1182/blood-2011-06-359646
– ident: ref223
  doi: 10.1016/j.ajps.2023.100854
– ident: ref173
  doi: 10.4049/jimmunol.1400752
– ident: ref201
  doi: 10.1016/j.biopha.2022.113324
– ident: ref28
  doi: 10.1038/ng912
– ident: ref200
  doi: 10.1016/j.lfs.2022.120375
– ident: ref190
  doi: 10.3389/fimmu.2021.629986
– ident: ref118
  doi: 10.1093/ckj/sfv076
– ident: ref153
  doi: 10.1111/eci.12275
– ident: ref261
  doi: 10.1101/2022.05.17.492303
– ident: ref181
  doi: 10.3389/fimmu.2017.01093
– ident: ref196
  doi: 10.1002/jgm.3015
– ident: ref208
  doi: 10.1016/j.omtm.2019.01.008
– ident: ref176
  doi: 10.2147/oarrr.s318826
– ident: ref252
  doi: 10.1007/s40120-020-00208-1
– ident: ref167
  doi: 10.3390/jcm10040626
– ident: ref222
  doi: 10.1038/d41587-023-00016-6
– ident: ref114
  doi: 10.1681/ASN.V11101957
– ident: ref247
  doi: 10.1016/j.ymthe.2024.01.005
– ident: ref265
  doi: 10.1073/pnas.1019338108
– ident: ref47
  doi: 10.1107/s0907444909000389
– ident: ref254
  doi: 10.1016/j.ophtha.2024.06.013
– ident: ref211
  doi: 10.1016/j.ijbiomac.2024.131802
– ident: ref210
  doi: 10.3390/cells11121881
– ident: ref269
  doi: 10.1016/j.cell.2021.03.025
– ident: ref72
  doi: 10.1172/jci118195
– ident: ref241
  doi: 10.1038/s41392-023-01309-7
– ident: ref21
  doi: 10.1073/pnas.82.3.859
– ident: ref204
  doi: 10.1038/s41467-020-19505-2
– ident: ref257
  doi: 10.1056/nejmoa2029073
– ident: ref205
  doi: 10.1080/14712598.2023.2183771
– ident: ref23
  doi: 10.4049/jimmunol.156.8.3051
– ident: ref73
  doi: 10.1016/s0161-5890(96)00078-8
– ident: ref142
  doi: 10.1016/j.ekir.2020.10.009
– ident: ref172
  doi: 10.3389/fimmu.2018.01057
– ident: ref1
  doi: 10.3389/fimmu.2022.931273
– ident: ref33
  doi: 10.1016/j.imbio.2023.152410
– ident: ref68
  doi: 10.1111/bjh.15790
– ident: ref101
  doi: 10.1016/s2352-3026(23)00315-0
– ident: ref145
  doi: 10.1007/s10238-019-00565-8
– ident: ref71
  doi: 10.1159/000463204
– ident: ref228
  doi: 10.1016/j.omtn.2024.102138
– ident: ref239
  doi: 10.1101/2022.01.28.478207
– ident: ref9
  doi: 10.4049/jimmunol.0903678
– ident: ref158
  doi: 10.1126/science.adg7942
– ident: ref178
  doi: 10.1038/ni.1655
– ident: ref69
  doi: 10.1016/s0140-6736(23)01524-6
– ident: ref264
  doi: 10.1126/science.1110359
– ident: ref233
  doi: 10.2217/epi-2023-0281
– ident: ref131
  doi: 10.3390/ijms222413647
– ident: ref242
  doi: 10.1016/j.cell.2020.03.023
– ident: ref146
  doi: 10.1155/2018/6051083
– ident: ref55
  doi: 10.1016/j.exer.2022.109248
– ident: ref136
  doi: 10.1002/ana.1255
– ident: ref193
  doi: 10.1016/j.immuni.2020.02.006
– ident: ref270
– ident: ref174
  doi: 10.1016/j.imbio.2012.08.232
– ident: ref187
  doi: 10.1126/science.aad1210
– ident: ref110
  doi: 10.1007/s00281-017-0663-8
– ident: ref246
  doi: 10.1038/s41467-023-42189-3
– ident: ref54
  doi: 10.1038/ng.439
– ident: ref179
  doi: 10.1016/j.smim.2018.02.003
– ident: ref83
  doi: 10.1002/ana.26626
– ident: ref113
  doi: 10.1681/asn.2004050380
– ident: ref98
  doi: 10.1016/j.omtm.2017.08.001
– ident: ref61
  doi: 10.4049/jimmunol.134.1.512
– ident: ref97
  doi: 10.1016/j.ajo.2024.02.021
– ident: ref225
  doi: 10.1126/sciadv.aao4774
– ident: ref27
  doi: 10.1007/BF01540901
– ident: ref237
  doi: 10.1152/ajpcell.00191.2022
– ident: ref106
  doi: 10.1038/s41593-020-0672-0
– ident: ref70
  doi: 10.1016/0161-5890(95)00099-2
– ident: ref78
  doi: 10.1016/j.jneuroim.2021.577767
– ident: ref37
  doi: 10.1182/blood-2022-163625
– ident: ref81
  doi: 10.1371/journal.pone.0195909
– ident: ref90
  doi: 10.4049/jimmunol.157.2.884
– ident: ref0
  doi: 10.1124/pharmrev.120.000072
– ident: ref209
  doi: 10.3390/biology12020186
– ident: ref42
  doi: 10.1038/nature04005
– ident: ref119
  doi: 10.1007/s00467-014-2863-y
– ident: ref243
  doi: 10.1038/s41573-023-00762-x
– ident: ref249
  doi: 10.1038/s12276-023-01086-x
– ident: ref82
  doi: 10.1182/bloodadvances.2018020644
– ident: ref93
– ident: ref29
  doi: 10.1016/j.imbio.2016.06.007
– ident: ref162
  doi: 10.1016/j.cell.2021.12.040
– ident: ref115
  doi: 10.1172/jci112522
– ident: ref48
  doi: 10.1002/prot.340030302
– ident: ref116
  doi: 10.1093/ndt/gfad140
– ident: ref134
  doi: 10.1056/nejmoa2212948
– ident: ref75
  doi: 10.1038/nbt1344
– ident: ref57
  doi: 10.1007/s00018-021-03796-9
– ident: ref121
  doi: 10.1038/s41581-018-0071-x
– ident: ref87
  doi: 10.1007/s40265-021-01643-6
– ident: ref199
  doi: 10.1038/nrg2971
– ident: ref25
  doi: 10.1182/blood-2008-04-151068
– ident: ref189
  doi: 10.1016/j.immuni.2016.08.003
– ident: ref88
  doi: 10.1007/s40265-023-01948-8
– ident: ref160
  doi: 10.1016/j.blre.2022.100995
– ident: ref40
  doi: 10.1074/jbc.m305175200
– ident: ref126
  doi: 10.1172/jci24521
– ident: ref6
  doi: 10.4049/jimmunol.1300780
– ident: ref50
  doi: 10.1038/ncomms10587
– ident: ref165
  doi: 10.1016/j.heliyon.2023.e19072
SSID ssj0002874940
Score 2.271185
SecondaryResourceType review_article
Snippet Complement is both evolutionary and scientifically old. It predates the adaptive immunity by some 600 million years and was first described in 1905 by Jules...
SourceID doaj
crossref
SourceType Open Website
Enrichment Source
Index Database
StartPage 577
SubjectTerms complement
complement therapeutics
complement-mediated disease
gene therapy
Title The future of complement therapeutics
URI https://doaj.org/article/d960d2e9f48249b4adb31d88b480549f
Volume 4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: Directory of Open Access Journals
  customDbUrl:
  eissn: 2768-6655
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002874940
  issn: 2768-6655
  databaseCode: DOA
  dateStart: 20210101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2768-6655
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002874940
  issn: 2768-6655
  databaseCode: M~E
  dateStart: 20210101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07T8MwELZQhRAL4inKSxlATFbjxPVjBETFQCsGQN0iP85SEWpRWxj57ficUIUBsbBkiE6R853j-86-fEfIeShwplhLHRhDeTSiSpiceu6lKRT4fqrNeb6Xo5Eaj_VDq9UX1oTV8sA1cD0fKbYvQAeuYqZgufG2ZF4py1VkGzrg6htZTyuZeklbRpJrntcqjaUsue7BJGaDBWplM8F-RKGWWH-KKoNtstXQweyqHsYOWYPpLtkYNgfee-QiujGrdT-yWchSAXja0MtaP04t9snT4Pbx5o42nQ2oQwkv6mxkPuDjxwLS9H1crWJe4ZEdGGVzYKy04JX2QUDupMDuMF5JZ7QADSzY8oB0prMpHJKMK2OC1iH3IufGBcuEDJpL6CMsgXcJ_X7TyjWy39h94rWK9D8hU8GkQmSqhEyXXK7s32rBi18trxG4lRUKVacb0X1V477qL_cd_cdDjskmDgtDClMnpLOcv8MpWXcfy8lifpZmRrwOP2-_AKsivLU
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+future+of+complement+therapeutics&rft.jtitle=Exploration+of+immunology&rft.au=Kolev%2C+Martin&rft.au=Rao%2C+Kollu+Nageswara&rft.au=Yeh%2C+Michael&rft.au=Parikh%2C+Atman&rft.date=2024-10-18&rft.issn=2768-6655&rft.eissn=2768-6655&rft.spage=577&rft.epage=615&rft_id=info:doi/10.37349%2Fei.2024.00161&rft.externalDBID=n%2Fa&rft.externalDocID=10_37349_ei_2024_00161
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2768-6655&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2768-6655&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2768-6655&client=summon